Oral Semaglutide 7 mg and 14 mg Doses Showed Superior Reductio... - 24 March 2019 05:00

NEW ORLEANS, LA., Mar. 24, 2019, /PRNewswire-AsiaNet/-- Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia(R) (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA1c reductions at 26 weeks was not confirmed. Presented today at th...

  Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 10... - 22 March 2019 01:12

PLYMOUTH MEETING, Pa., March 21, 2019 /PRNewswire-AsiaNet/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases ( https://c...

  Merck Opens First M Lab(TM) Collaboration Center in Europe - 20 March 2019 20:30

DARMSTADT, Germany, March 20, 2019 /PRNewswire-AsiaNet/ -- - Molsheim, France center supports pharmaceutical and biotechnology customers from pre-clinical through full-scale production in non-GMP environment - Hands-on customer access to Merck's Life Science product portfolio and technical expertise ...

  Merck and Pfizer Announce Discontinuation of Phase III JAVELIN... - 20 March 2019 10:37

DARMSTADT, Germany and NEW YORK, March 20, 2019, /PRNewswire-AsiaNet/-- Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chem...

  UK Schools Rank Last in Providing Oral Health Education, FDI S... - 20 March 2019 08:00

GENEVA, March 20, 2019 /PRNewswire-AsiaNet/ -- Today on World Oral Health Day (WOHD), FDI World Dental Federation (FDI) released the results of a survey from 13 countries, which asked parents with children aged 5–16 if their child's school provided lessons on good oral care. Poor oral health c...

  Merck To Collaborate with GenScript to Accelerate Cell and Gen... - 19 March 2019 21:30

DARMSTADT, Germany, March 19, 2019 /PRNewswire-AsiaNet/ -- -- Collaboration to build global-standard platform for plasmid and virus manufacturing in China -- Merck plans to provide comprehensive products, services and training to GenScript on manufacturing Merck ( https://c212.net/c/link/?t=0&l=en&...

  Nyxoah Receives European CE Mark Approval for the Genio® Syste... - 19 March 2019 19:00

SAINT-GUIBERT, Belgium, March 19, 2019 /PRNewswire-AsiaNet/ -- Nyxoah S.A., a healthtech company focusing on the development of innovative solutions and services for sleep related disorders, today announced that the company has received CE Mark approval for the Genio(R) system in Europe. The Genio...

  New Report Shows Rapid Damage to Milk Nutrients by Light - 18 March 2019 13:00

WILMINGTON, Delaware, Mar. 18, 2019 /PRNewswire-AsiaNet/-- --Noluma Reveals Milk Loses 50% of Nutrients after only 16 Hours of Retail Lighting Exposure(1) Noluma International, LLC, the leader in light protection technology, released new evidence today highlighting the rapid degradation of nutrients i...

  Merck Announces Collaboration With Iktos for Generative Artifi... - 15 March 2019 01:08

DARMSTADT, Germany, March 15, 2019 /PRNewswire-AsiaNet/ -- Not intended for US, Canada and UK-based media - Collaboration agreement enables Merck access to Iktos AI technology across three drug discovery projects - Generative modelling AI technology enables rapid and cost-effective design of novel dr...

  Scientists clarify what probiotics are and what they are not - 14 March 2019 08:00

LOS ANGELES, March 14, 2019 /PRNewswire-AsiaNet/ -- - A new scientific paper calls for strict adherence to the scientific definition, ensuring improper use of the term doesn't mislead consumers or limit advancements in the emerging field of microbiome science. - Authored by Dr. Gregor...